Royalty Pharma Stock (NASDAQ: RPRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 108.00 / 2.67M |
Day Range | - - - |
52 Wk Range | 25.20 - 31.66 |
Market Cap | $12.35B |
P/E Ratio | 18.36 |
Dividend Yield | 3.05% |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 3.4% |
Days to Cover | 6.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.
Other companies in Royalty Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
Royalty Pharma has a consensus price target of $46.63.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $27.55 last updated September 23, 2024 at 7:49 AM EDT.
A quarterly cash dividend of 0.21 per share of Class A Common Stock. The quarterly cash dividend was payable on September 13, 2024 to stockholders of record on August 16, 2024.
Royalty Pharma’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.